Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
Study Information
Alliance Study ID: NCCTG-N02C3
NCT Study ID (ClinicalTrials.gov): NCT00075855
Alliance Committee: Cancer Control
Disease or Cancer Type: Other Cancer
Alliance Study Chair: Charles L. Loprinzi, MD
Status: COMPLETED
Study Description
RATIONALE: The hormone testosterone may improve the libido (sex drive) in women. It is not yet known whether testosterone is effective in improving libido in female cancer survivors.
PURPOSE: This randomized phase III trial is studying how well low-dose testosterone works to improve libido in postmenopausal cancer survivors.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information